Technical Analysis for KPRX - Kiora Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 3.60 -0.55% -0.02
KPRX closed down 0.55 percent on Friday, November 1, 2024, on approximately normal volume. It was able to find support at its 50 day moving average.
Earnings due: Nov 7
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Gapped Up Strength -0.55%
Down 3 Days in a Row Weakness -0.55%
Inside Day Range Contraction -2.70%
Overbought Stochastic Strength -2.70%

   Recent Intraday Alerts

Alert Time
Up 1% about 21 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
10 DMA Resistance about 22 hours ago
50 DMA Resistance about 22 hours ago
60 Minute Opening Range Breakout 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kiora Pharmaceuticals, Inc. Description

EyeGate Pharmaceuticals Inc. is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye. EyeGate's lead product, Ocular Bandage Gel ('OBG'), is based on a modified form of the natural polymer hyaluronic acid. The objective of OBG is to protect the ocular surface in order for the body to re-epithelialize the cornea and improve ocular surface integrity. The product is applied as a clear topical gel, to the damaged ocular surface, and possesses unique properties that help hydrate and protect the ocular surface to allow for wound healing. EyeGate is in clinical evaluation for two different patient populations: (1) patients undergoing photorefractive keratectomy ('PRK') surgery to demonstrate corneal wound repair after refractive surgery; and (2) patients with punctate epitheliopathies ('PE') as a result of dry eye to promote reduction of PEs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Pharmaceutical Disease Surgery Disorders Eye Surgery Hyaluronic Acid Lasik Refractive Surgery

Is KPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.982
52 Week Low 3.0
Average Volume 24,909
200-Day Moving Average 4.55
50-Day Moving Average 3.54
20-Day Moving Average 3.49
10-Day Moving Average 3.66
Average True Range 0.23
RSI (14) 51.22
ADX 15.28
+DI 23.72
-DI 17.62
Chandelier Exit (Long, 3 ATRs) 3.45
Chandelier Exit (Short, 3 ATRs) 3.78
Upper Bollinger Bands 3.92
Lower Bollinger Band 3.06
Percent B (%b) 0.62
BandWidth 24.69
MACD Line 0.05
MACD Signal Line 0.02
MACD Histogram 0.0295
Fundamentals Value
Market Cap 27.68 Million
Num Shares 7.69 Million
EPS 0.78
Price-to-Earnings (P/E) Ratio 4.62
Price-to-Sales 535.59
Price-to-Book 33.53
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.87
Resistance 3 (R3) 3.87 3.78 3.82
Resistance 2 (R2) 3.78 3.71 3.78 3.81
Resistance 1 (R1) 3.69 3.67 3.73 3.69 3.79
Pivot Point 3.60 3.60 3.62 3.60 3.60
Support 1 (S1) 3.51 3.53 3.56 3.51 3.41
Support 2 (S2) 3.42 3.49 3.42 3.39
Support 3 (S3) 3.33 3.42 3.38
Support 4 (S4) 3.33